James Bligh

James Bligh is recorded as CEO at CDT Equity Inc. (CDT) since August 31, 2026, CFO at CDT Equity Inc. (CDT) since August 4, 2025 and Board Member at CDT Equity Inc. (CDT) since January 1, 2023. The newest filing on record that lists James Bligh as Board Member at CDT Equity Inc. (CDT) is dated August 11, 2026. CDT Equity Inc. reported in an 8-K filed September 1, 2026 that James Bligh was appointed Chief Executive Officer, effective August 31, 2026. CDT Equity Inc. reported in an 8-K filed August 8, 2025 that James Bligh was appointed permanent Chief Financial Officer, effective August 4, 2025. CDT Equity Inc. reported in an 8-K filed September 29, 2023 that James Bligh was appointed directors of the Company, effective September 22, 2023. The proxy statement of CDT Equity Inc. reports total compensation of $1,450,922 for James Bligh in fiscal 2025, including a base salary of $528,000. Disclosed compensation is on record for 3 fiscal years. CDT Equity Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at CDT Equity Inc. includes Andrew Regan (CEO and Board Member), David Tapolczay (CEO and Board Member), Chele Chiavacci Farley (Chairman and Board Member) and 6 others.